Other function- path field study analytes biomarkers to be analyzed
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510013C
- Awardee
-
Genway Biotech, LLC UEI Q7KGV5SPMHU6 Part of Aviva Systems Biology Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,879,504
Award facts
- Opportunity
-
- 15223SOL00018 Solicitation number
- PATH Study Analysis: Assays of Multiple Analytes Award Notice · Posted Mar 31, 2015
- Contract value 71% obligated
-
- $2,879,503.54 Current, with exercised options
- $4,075,691.59 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$145,766 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $617,536 | |
| Funding Only Action | -$28,748 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $650,992 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $885,489 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $900,000 |
Show all 11
About this award
This is a $4,075,691.59 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Genway Biotech, LLC, a small business. The contract is for a "PATH FIELD STUDY ANALYTES BIOMARKERS TO BE ANALYZED" requirement, with a period of performance ending on May 10, 2020. Genway Biotech, LLC is a subsidiary of Aviva Systems Biology Corporation. The contract was set aside for total small business participation.
Quick answers
Who was awarded contract HHSF223201510013C?
HHSF223201510013C was awarded to Genway Biotech, LLC by Food and Drug Administration (Department of Health and Human Services) on May 11, 2015.
How much is contract HHSF223201510013C worth?
The government has obligated $2,879,504 on HHSF223201510013C. Its potential value, with all options, is $4,075,692.
Was contract HHSF223201510013C competed?
The extent of competition for HHSF223201510013C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award